Skyline Ventures is a venture capital firm that specialises in investing in outstanding product-focused healthcare companies with expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research. The company was founded in 1997 by a group of medical professionals led by John Freund and Eric M. Gordon. Its headquarters is located in Palo Alto, California.
Skyline Ventures has approximately $800 million under management. It targets to invest $15-35 million per portfolio company over the life of the company. Among the companies included in Skyline Ventures' portfolio are AcelRx Pharmaceuticals, Avidia, Crescendo Bioscience, and NovaCardia.